待处理
入排:排除
图源:待检查
Efficacy and safety of secukinumab in patients with active psoriatic arthritis at Week 16 and up to 52 weeks: Results from a Phase III, randomized, double-blind, placebo-controlled bridging study in China.
Xiaomei Leng, Yi Liu, Lin Tang, Lingyun Sun, Jingyang Li, Jiankang Hu, Hongbin Li, Shanhui Ye, Lijun Wu, Xinwang Duan, Huaxiang Liu, Ting Li, Yongfu Wang, Mercedes Bustamante, Sharonjeet Kaur, Rong Fu, Yuan Tian, Jing Yang, Pellet Pascale, Xiaofeng Zeng
Chin Med J (Engl) 10.1097/CM9.0000000000003924
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板